High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma

Activin A (ActA)/follistatin (FST) signaling has been shown to be deregulated in different tumor types including lung adenocarcinoma (LADC). Here, we report that serum ActA protein levels are significantly elevated in LADC patients (n=64) as compared to controls (n=46, p=0.015). ActA levels also cor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Hoda, Mir Alireza, Rozsas, Anita, Lang, Elisabeth, Klikovits, Thomas, Lohinai, Zoltan, Torok, Szilvia, Berta, Judit, Bendek, Matyas, Berger, Walter, Hegedus, Balazs, Klepetko, Walter, Renyi-Vamos, Ferenc, Grusch, Michael, Dome, Balazs, Laszlo, Viktoria
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2016
Schlagworte:
Research Paper: Pathology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924649/
https://ncbi.nlm.nih.gov/pubmed/26950277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7796
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge